Meridian Bioscience Inc
NASDAQ:VIVO
Revenue Breakdown
Breakdown by Geography
Meridian Bioscience Inc
Breakdown by Segments
Meridian Bioscience Inc
Total Revenue:
333m
USD
|
Life Science:
177.1m
USD
|
Diagnostics:
155.9m
USD
|
Non Molecular Assays:
137.7m
USD
|
Molecular Reagents:
91.8m
USD
|
Gastrointestinal Assays:
87.6m
USD
|
Immunological Reagents:
85.3m
USD
|
Other Diagnostics:
27.5m
USD
|
Respiratory Illness Assays:
26.6m
USD
|
Molecular Assays:
18.2m
USD
|
Blood Chemistry Assays:
14.2m
USD
|